略過巡覽連結
  • OBM
    • Management Team
    • Board of Directors
  • Technology
    • Chelating-Complex Micelle
    • Trigger Release Technology
  • R&D
    • R&D
  • Pipeline
    • Pipeline
    • OBM's Project
  • Press Room
    • LATEST NEWS
  • Contact us
    • Our Location
  • [2019-06-21]Boarding director re-election. OBM + AI comes back strong to BioTaiwan.
  • [2018-12-04]Original BioMedicals (6483) sings up the memorandum of understanding with NanoRay Biotech Co., Ltd.
  • [2018-03-12]Original BioMedicals sings up product sales and development agreement with Beijing Meone Pharma.
Original BioMedicals special patented design, "Chelating-complex micelle" and "Trigger Release Technology" bring previously approved FDA drugs to a brighter future

For more information,
licensing, technologies.
Please email us at

+886-6-5055433
Info@i-obm.com


OBM|Technology|R&D|Pipeline|Press Room|Contact us
Copyright © 2024 Original BioMedicals Co., Ltd. All rights reserved
View Count: | Latest update:2024/08/05 | Management Login